{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T13:42:16Z","timestamp":1741095736205,"version":"3.38.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,4]]},"DOI":"10.7759\/cureus.80021","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T12:59:26Z","timestamp":1741093166000},"source":"Crossref","is-referenced-by-count":0,"title":["Decline of Persistent Jaundice in a Patient With Autoimmune Hepatitis and Vanishing Bile Duct Syndrome Treated With Elobixibat for Constipation"],"prefix":"10.7759","author":[{"given":"T\u00e2n","family":"Tr\u1ea7n Th\u1ecb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiro","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Inukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL Clinical Practice Guidelines: autoimmune hepatitis","volume":"63","year":"2015","unstructured":"EASL Clinical Practice Guidelines. autoimmune hepatitis. J Hepatol. 2015, 63:971-1004. 10.1016\/j.jhep.2015.06.030","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases","volume":"72","author":"Mack CL","year":"2020","unstructured":"Mack CL, Adams D, Assis DN, et al.. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases. Hepatology. 2020, 72:671-722. 10.1002\/hep.31065","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2957\/kanzo.66.1","article-title":"PBC-AIH overlap Clinical Practice Statement 2024 Ministry of Health, Labour and Welfare Policy Research Project \"Survey and Research on Refractory Hepatic and Biliary Tract Diseases\" Group","volume":"66","author":"Kugiyama Y","year":"2025","unstructured":"Kugiyama Y, Kawata K, Namisaki T, et al.. PBC-AIH overlap Clinical Practice Statement 2024 Ministry of Health, Labour and Welfare Policy Research Project \"Survey and Research on Refractory Hepatic and Biliary Tract Diseases\" Group. J-Stage. 2025, 66:1-6. 10.2957\/kanzo.66.1","journal-title":"J-Stage"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9051449","article-title":"Treatment of overlap syndromes in autoimmune liver disease: a systematic review and meta-analysis","volume":"9","author":"Freedman BL","year":"2020","unstructured":"Freedman BL, Danford CJ, Patwardhan V, Bonder A. Treatment of overlap syndromes in autoimmune liver disease: a systematic review and meta-analysis. J Clin Med. 2020, 9:10.3390\/jcm9051449","journal-title":"J Clin Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008009","article-title":"Acute vanishing bile duct syndrome after therapy with cephalosporin, metronidazole, and clotrimazole: a case report","volume":"96","author":"Zhao Z","year":"2017","unstructured":"Zhao Z, Bao L, Yu X, et al.. Acute vanishing bile duct syndrome after therapy with cephalosporin, metronidazole, and clotrimazole: a case report. Medicine (Baltimore). 2017, 96:e8009. 10.1097\/MD.0000000000008009","journal-title":"Medicine (Baltimore)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2302\/kjm.2022-0036-IR","article-title":"Current management of chronic constipation in Japan","volume":"72","author":"Masaoka T","year":"2023","unstructured":"Masaoka T. Current management of chronic constipation in Japan. Keio J Med. 2023, 72:95-101. 10.2302\/kjm.2022-0036-IR","journal-title":"Keio J Med"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.5056\/jnm20263","article-title":"Safety and efficacy of elobixibat, an ileal bile acid transporter inhibitor, in elderly patients with chronic idiopathic constipation according to administration time: interim analysis of post-marketing surveillance","volume":"28","author":"Nakajima A","year":"2022","unstructured":"Nakajima A, Fujimaki M, Arai Y, Emori K. Safety and efficacy of elobixibat, an ileal bile acid transporter inhibitor, in elderly patients with chronic idiopathic constipation according to administration time: interim analysis of post-marketing surveillance. J Neurogastroenterol Motil. 2022, 28:431-41.","journal-title":"J Neurogastroenterol Motil"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases","volume":"69","author":"Lindor KD","year":"2019","unstructured":"Lindor KD, Bowlus CL, Boyer J, Levy C, Mayo M. Primary biliary cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases. Hepatology. 2019, 69:394-419. 10.1002\/hep.30145","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-021-10276-6","article-title":"APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis","volume":"16","author":"You H","year":"2022","unstructured":"You H, Ma X, Efe C, et al.. APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis. Hepatol Int. 2022, 16:1-23. 10.1007\/s12072-021-10276-6","journal-title":"Hepatol Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.109680","article-title":"Canal of Hering loss is an initiating step for primary biliary cholangitis (PBC): a hypothesis","volume":"140","author":"Theise ND","year":"2020","unstructured":"Theise ND, Crawford JM, Nakanuma Y, Quaglia A. Canal of Hering loss is an initiating step for primary biliary cholangitis (PBC): a hypothesis. Med Hypotheses. 2020, 140:109680. 10.1016\/j.mehy.2020.109680","journal-title":"Med Hypotheses"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26020","article-title":"Keratin 19 demonstration of canal of Hering loss in primary biliary cirrhosis: \"minimal change PBC\"?","volume":"57","author":"Khan FM","year":"2013","unstructured":"Khan FM, Komarla AR, Mendoza PG, Bodenheimer HC Jr, Theise ND. Keratin 19 demonstration of canal of Hering loss in primary biliary cirrhosis: \"minimal change PBC\"?. Hepatology. 2013, 57:700-7. 10.1002\/hep.26020","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001876","article-title":"Early histopathologic changes in primary biliary cholangitis: does 'minimal change' primary biliary cholangitis exist? A pathologist's view","volume":"33","author":"Chatzipantelis P","year":"2021","unstructured":"Chatzipantelis P, Giatromanolaki A. Early histopathologic changes in primary biliary cholangitis: does 'minimal change' primary biliary cholangitis exist? A pathologist's view. Eur J Gastroenterol Hepatol. 2021, 33:e7-e12. 10.1097\/MEG.0000000000001876","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4377-1604-7.00158-5","article-title":"158 - Diseases of the Gallbladder and Bile Ducts","author":"Afdhal NH","year":"2012","unstructured":"Afdhal NH. 158 - Diseases of the Gallbladder and Bile Ducts. Goldman\u2019s Cecil Medicine. Elsevier, 2012. 1:1011-20. 10.1016\/B978-1-4377-1604-7.00158-5"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i2.366","article-title":"Vanishing bile duct syndrome in Hodgkin's lymphoma: a case report and literature review","volume":"23","author":"Bakhit M","year":"2017","unstructured":"Bakhit M, McCarty TR, Park S, Njei B, Cho M, Karagozian R, Liapakis A. Vanishing bile duct syndrome in Hodgkin's lymphoma: a case report and literature review. World J Gastroenterol. 2017, 23:366-72. 10.3748\/wjg.v23.i2.366","journal-title":"World J Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11123253","article-title":"Vanishing bile duct syndrome in an adult patient: case report and review of the literature","volume":"11","author":"Izzo P","year":"2022","unstructured":"Izzo P, Gallo G, Codacci Pisanelli M, et al.. Vanishing bile duct syndrome in an adult patient: case report and review of the literature. J Clin Med. 2022, 11:3253. 10.3390\/jcm11123253","journal-title":"J Clin Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.03.004","article-title":"Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome","volume":"8","author":"Kuiper EM","year":"2010","unstructured":"Kuiper EM, Zondervan PE, van Buuren HR. Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome. Clin Gastroenterol Hepatol. 2010, 8:530-4. 10.1016\/j.cgh.2010.03.004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2478\/jtim-2020-0016","article-title":"Autoimmune hepatitis: clinical characteristics and predictors of biochemical response to treatment","volume":"8","author":"Tasneem AA","year":"2020","unstructured":"Tasneem AA, Luck NH. Autoimmune hepatitis: clinical characteristics and predictors of biochemical response to treatment. J Transl Int Med. 2020, 8:106-11. 10.2478\/jtim-2020-0016","journal-title":"J Transl Int Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12227047","article-title":"Primary biliary cholangitis (PBC)-autoimmune hepatitis (AIH) variant syndrome: clinical features, response to therapy and long-term outcome","volume":"12","author":"Graf M","year":"2023","unstructured":"Graf M, Lange CM, Langer MM, et al.. Primary biliary cholangitis (PBC)-autoimmune hepatitis (AIH) variant syndrome: clinical features, response to therapy and long-term outcome. J Clin Med. 2023, 12:10.3390\/jcm12227047","journal-title":"J Clin Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2015.21.2.150","article-title":"Retrospective analysis of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome in Korea: characteristics, treatments, and outcomes","volume":"21","author":"Park Y","year":"2015","unstructured":"Park Y, Cho Y, Cho EJ, Kim YJ. Retrospective analysis of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome in Korea: characteristics, treatments, and outcomes. Clin Mol Hepatol. 2015, 21:150-7. 10.3350\/cmh.2015.21.2.150","journal-title":"Clin Mol Hepatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.285","article-title":"Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation","volume":"106","author":"Wong BS","year":"2011","unstructured":"Wong BS, Camilleri M, McKinzie S, Burton D, Graffner H, Zinsmeister AR. Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation. Am J Gastroenterol. 2011, 106:2154-64. 10.1038\/ajg.2011.285","journal-title":"Am J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/336461-decline-of-persistent-jaundice-in-a-patient-with-autoimmune-hepatitis-and-vanishing-bile-duct-syndrome-treated-with-elobixibat-for-constipation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T12:59:28Z","timestamp":1741093168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/336461-decline-of-persistent-jaundice-in-a-patient-with-autoimmune-hepatitis-and-vanishing-bile-duct-syndrome-treated-with-elobixibat-for-constipation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.80021","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,4]]}}}